Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
As per available reports about 6 relevant Journals, 2 Conferences, 268 Workshops are presently dedicated exclusively to Viral Transcriptomics and about 685 articles are being published on Viral Transcriptomics.
Viral Transcriptomics and metatranscriptome information is important for predicting resistance to specific antibiotics, understanding host-pathogen immune interactions, quantifying gene expression changes, and tracking disease progression. Next-generation RNA-Seq (RNA sequencing) of bacteria, viruses, and other microbes has become a standard method for analyzing transcriptome and metatranscriptome information. The viral transcriptome is the comprehensive set of RNAs encoded by the virus's genome. Metatranscriptomes encompass all RNAs encoded by a group of organisms in a complex sample.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Baculovirus-insect cell technologies are applied in the production of complex proteins, veterinary and human vaccines, gene delivery vectors‚ and biopesticides. Viral Transcriptomics conferences provide an insight to the better understanding of how baculoviruses and insect cells interact would facilitate baculovirus-based production. While complete genomic sequences are available for over 58 baculovirus species, little insect genomic information is known. The release of the Bombyx mori and Plutella xylostella genomes, the accumulation of EST sequences for several Lepidopteran species, and especially the availability of two genome-scale analysis tools, namely oligonucleotide microarrays and next generation sequencing (NGS), have facilitated expression studies to generate a rich picture of insect gene responses to baculovirus infections. This review presents current knowledge on the interaction dynamics of the baculovirus-insect system‚ which is relatively well studied in relation to nucleocapsid transportation, apoptosis, and heat shock responses, but is still poorly understood regarding responses involved in pro-survival pathways, DNA damage pathways, protein degradation, translation, signaling pathways, RNAi pathways, and importantly metabolic pathways for energy, nucleotide and amino acid production. We discuss how the two genome-scale transcriptomic tools can be applied for studying such pathways and suggest that proteomics and metabolomics can produce complementary findings to transcriptomic studies.
Bacterial, viral, and other microbial RNA-Seq experiments enable annotation and quantification of comprehensive microbial transcripts. Cellular RNA is extracted and converted to cDNA, which is used to prepare sequencing libraries.
The Agricultural Microbials Market by Type (bacteria, fungi, virus, and protozoa), Crop Type (Cereals & grains, oilseeds, & pulses, fruit & vegetable) & Region is estimated to worth $2,182.78 million in 2014, and is projected to reach $4,556.37 million by 2019, at a CAGR of 15.3%. In 2013, North America was the largest market; this market is projected to grow to $1,759.84 million by 2019, at a CAGR of 15.1%, as studied from 2014. Europe is the second-largest market of agricultural microbials, and is projected to grow at a CAGR of 15.4% during the period under review.
Along with this the global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018.
Latest reports say about Cancer Immunology and Oncolytic Virology: Technologies and Global Markets provide an overview of the current and potential global market for cancer immunotherapy and virology. The report provides comprehensive information on a number of the most common cancers, highlighting global incidence and prevalence. It identifies the need for more effective drugs for treatment of these diseases. It presents a comprehensive analysis of the current state of cancer immunotherapy and where this field is going. Also, it examines the current state of oncolytic virology and where this nascent field appears to be heading. Important trends in each field, clinical trials and results, new developments and sales forecasts for cancer immunotherapy from 2011 through 2018 are provided in the report. In addition, sales forecasts are presented for oncolytic virology covering the years 2011 through 2023.
1. 2nd Transcriptomics Conference
August 18-20, 2016 Portland, Oregon USA
2. 5th Virology Congress
December 07-09, 2015 Atlanta, USA
3. 7th Virology Congress
November 21-23, 2016 Baltimore, USA
5. 6th Euro Virology Congress and Expo
March 10-12, 2016 Madrid, Spain
6. Viruses 2016 - At the Forefront of Virus-Host Interactions, Basel, Switzerland
7. Positive-Strand RNA Viruses, Austin, USA
8. Molecular Virology and Microbiology Conference, London, UK
9. From Molecular Mechanism to Pathogenesis and Prevention, Girona, Spain
10. Antiviral Research Conference, La Jolla, USA
11. Annual Meeting of the Society for Virology, Munster, Germany
Relevant Societies and Associations:
1. The Association of Bimolecular Resource Facilities (ABRF), Bethesda, MD, USA
2. American Society of Gene and Cell Therapy, Milwaukee, Wisconsin, USA
3. Triangle Chromatography Discussion Group, USA
4. American Chemical Society
5. American Society for Microbiology, USA
6. RNA Society - Maryland, USA
7. University of Nebraska Medical Centre, Omaha, Nebraska, USA
8. US HUPO, Santa Fe, New Mexico, USA
9. The Protein Society, USA
10. Society for Industrial Microbiology and Biotechnology, Fairfax, Virginia, USA
11. Federation of American Societies for Experimental Biology (FASEB), Maryland, USA
12. BioFlorida- Life Science Community
13. European Society of Human Genetics, Vienna, Austria
14. European Proteimcs Association (EuPA), UK
15. British Society for Proteome Research (BSPR), UK
16. Swiss Proteomics Society (SPS), Switzerland
17. Proteomics Society, India
1. Affymetrix - Santa Clara, California USA
2. Roche NimbleGen Inc. Madison, Wisconsin, United States
3. SciGene Sunnyvale, California, United States
4. Arrayit Corporation
5. DNAmicroarray California, USA
6. LC Sciences, Houston, TX, US
7. SeqWright Genomic Services (a unit of GE health care)
This page will be updated regularly.
This page was last updated on 17th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising